Vascular Medicine

Society for Vascular Medicine Elects Dr. Herb Aronow as its New President

Retrieved on: 
Friday, June 18, 2021
Vascular Medicine, Angiology

CHICAGO, June 18, 2021 /PRNewswire/ --Herbert D. Aronow, MD, MPH, FSVM is the new president of the Society for Vascular Medicine.

Key Points: 
  • CHICAGO, June 18, 2021 /PRNewswire/ --Herbert D. Aronow, MD, MPH, FSVM is the new president of the Society for Vascular Medicine.
  • Aronow has been active as a leader in the Society during his 16 years of membership, having served two terms each as a Trustee-At-Large, Secretary, and President-Elect.
  • "It is an honor to serve as SVM's next President and I look forward to working alongside the Board of Trustees and other Society leaders to advance the vascular medicine discipline and the care of vascular patients," Aronow said.
  • The Society for Vascular Medicine (SVM) is a professional organization founded in 1989 to improve the integration of vascular biological advances into medical practice, and to maintain high standards of clinical vascular medicine.

Natalie A. Marks, MD is recognized by Continental Who's Who

Retrieved on: 
Thursday, September 17, 2020
Surgical specialties, Vascular surgery, Vascular Medicine, Medical specialty, Angiology, Health care, Medicine, Health, Claudio J. Schonholz, Draft:Hiranya A. Rajasinghe

Marks, MD, is being recognized by Continental Who's Who as a Pinnacle Professional in the field of medicine as a Vascular Surgeon with Vascular Institute or New York / Total Vascular Care.

Key Points: 
  • Marks, MD, is being recognized by Continental Who's Who as a Pinnacle Professional in the field of medicine as a Vascular Surgeon with Vascular Institute or New York / Total Vascular Care.
  • Marks, a vascular medicine specialist with Vascular Institute of New York is trained in the medical management of vascular disorders with expertise in minimally invasive Interventional treatment of vascular disease.
  • They are committed to providing patients with the most innovative and up-to-date treatments for vascular disease.
  • She is an invited member of the American College of Physicians and a Fellow of the American Society for Vascular Medicine.

Results from 10 Highly Anticipated Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA20

Retrieved on: 
Wednesday, September 9, 2020
Vascular surgery, Interventional radiology, Radiology, Vascular Medicine

SAN JOSE, Calif., Sept. 9, 2020 /PRNewswire/ --Leading researchers and physicians will present results from 10 clinical trials that focus on vascular interventional technology and treatment solutions on Friday, November 6, and Saturday, November 7, during the 18th annual VIVA (Vascular InterVentional Advances) conference, which will be held virtually.

Key Points: 
  • SAN JOSE, Calif., Sept. 9, 2020 /PRNewswire/ --Leading researchers and physicians will present results from 10 clinical trials that focus on vascular interventional technology and treatment solutions on Friday, November 6, and Saturday, November 7, during the 18th annual VIVA (Vascular InterVentional Advances) conference, which will be held virtually.
  • The trial results and data will be presented for the first time during VIVA's immersive virtual experience.
  • Since 2003, VIVA's vascular education symposium has brought together a global, multispecialty faculty to present a variety of talks and live case presentations from clinical centers around the world.
  • Attendees include an international audience of interventional cardiologists, interventional radiologists, vascular surgeons, and endovascular medicine specialists.

Natalie A. Marks, MD, is being recognized by Continental Who's Who

Retrieved on: 
Monday, July 6, 2020
Medical specialties, Surgery, Medicine, Vascular Medicine, Specialty, Vascular surgery, Interventional radiology, Peter H. Lin

They offer a full spectrum of surgical and endovascular methods for the treatment of vascular disorders.

Key Points: 
  • They offer a full spectrum of surgical and endovascular methods for the treatment of vascular disorders.
  • Marks, an acclaimed vascular medicine specialist with the institute is trained in the medical management of vascular disorders with expertise in minimally invasive Interventional treatment of vascular disease.
  • They are also committed to providing patients with the most innovative and up-to-date treatments for vascular disease.
  • He has acted as her mentor, role model and continuing source of professional and personal inspiration since the start of her career.

Results From 20 Highly Anticipated Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA19

Retrieved on: 
Monday, September 16, 2019
Medicine, Interventional radiology, Vascular surgery, Health care, Health, Interventional cardiology, Vascular Medicine, Radiology, Katharine L. Krol, Anne C. Roberts

VIVA (Vascular InterVentional Advances) is an annual vascular education symposium that brings together a global, multispecialty faculty to present a variety of talks and live case presentations from clinical centers around the world.

Key Points: 
  • VIVA (Vascular InterVentional Advances) is an annual vascular education symposium that brings together a global, multispecialty faculty to present a variety of talks and live case presentations from clinical centers around the world.
  • Attendees include an international audience of interventional cardiologists, interventional radiologists, vascular surgeons, and endovascular medicine specialists.
  • The trial results and data will be presented for the first time during the meeting on Tuesday and Wednesday and highlighted in scheduled press conferences on Monday and Tuesday.
  • Our team of specialists in vascular medicine, interventional cardiology, interventional radiology, and vascular surgery is driven by the passion to advance the field and improve patient outcomes.

Final Five Unpublished Vascular Clinical Trial Results Announced at VIVA 18

Retrieved on: 
Wednesday, November 7, 2018
Medicine, Radiology, Clinical medicine, Medical imaging, Vascular surgery, Vascular Medicine, Interventional radiology, Interventional cardiology, Angiography

LAS VEGAS, Nov. 7, 2018 /PRNewswire/ -- VIVA Physicians , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the final five of 19 highly anticipated late-breaking clinical trial results at VIVA 18 hosted at the Wynn Las Vegas.

Key Points: 
  • LAS VEGAS, Nov. 7, 2018 /PRNewswire/ -- VIVA Physicians , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the final five of 19 highly anticipated late-breaking clinical trial results at VIVA 18 hosted at the Wynn Las Vegas.
  • Trial enrollment began in October 2017 and was completed in May 2018, with 21 patients having completed trial and procedure enrollment and undergoing follow-up.
  • Adjudication of the Doppler ultrasound results and angiographic follow-up results has been conducted with a core lab.
  • Our team of specialists in vascular medicine, interventional cardiology, interventional radiology, and vascular surgery is driven by the passion to advance the field for optimal patient care.

New Unpublished Vascular Clinical Trial Results Announced at VIVA 18

Retrieved on: 
Wednesday, November 7, 2018
Medicine, Interventional radiology, Surgical specialties, Health care, Interventional cardiology, Clinical medicine, Vascular surgery, Vascular Medicine, Angiology

LAS VEGAS, Nov. 7, 2018 /PRNewswire/ -- VIVA Physicians , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces five more of the nineteen highly anticipated late-breaking clinical trial results at VIVA 18 hosted at the Wynn Las Vegas.

Key Points: 
  • LAS VEGAS, Nov. 7, 2018 /PRNewswire/ -- VIVA Physicians , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces five more of the nineteen highly anticipated late-breaking clinical trial results at VIVA 18 hosted at the Wynn Las Vegas.
  • This is the first global, multicenter, randomized DCB trial to prove safety and show a benefit over PTA.
  • The Large Bore Closer vascular sealing system (Rex Medical) delivers a fully resorbable sealing mechanism to the femoral arterial access site.
  • Our team of specialists in vascular medicine, interventional cardiology, interventional radiology, and vascular surgery is driven by the passion to advance the field for optimal patient care.

Groundbreaking Endovascular Clinical Trial Results Announced At VIVA 18

Retrieved on: 
Tuesday, November 6, 2018
Health, Las Vegas Valley, Vascular surgery, Clinical trial, Las Vegas, Vascular Medicine

LAS VEGAS, Nov. 6, 2018 /PRNewswire/ -- VIVA Physicians , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the next four of 19 highly anticipated late-breaking clinical trial results at VIVA 18 hosted at the Wynn Las Vegas.

Key Points: 
  • LAS VEGAS, Nov. 6, 2018 /PRNewswire/ -- VIVA Physicians , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the next four of 19 highly anticipated late-breaking clinical trial results at VIVA 18 hosted at the Wynn Las Vegas.
  • Follow-up visits occurred at 30 days, and 3, 6, 12, and 18 months, and will continue through 36 months.
  • Independent review of the data is performed by the Cleveland Clinic core lab and Syntactx clinical events committee at key evaluation points.
  • Results of the study at 12 months were presented at the Society for Vascular Surgery meeting in June 2018.